Agency
United Hospital District INC.
United Hospital District INC. was paid $5.85M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoUNITED HOSPITAL DISTRICT INC.
BLUE EARTH, MN 56013
BLUE EARTH, MN 56013
33aNPI1952307688assigned 06/27/2005
33bProvider typeHome Health Agency
28Total paid$5.85M
24GClaims115,712
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Home Health Agency providers in Minnesota
Rank by total paid#103 of 381
Median peer was paid$1.47M
This provider vs. median4.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,210 | $271K | |
| 2019 | 14,064 | $1.08M | |
| 2020 | 15,730 | $922K | |
| 2021 | 18,437 | $960K | |
| 2022 | 19,113 | $898K | |
| 2023 | 20,157 | $923K | |
| 2024incomplete | 16,001 | $787K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 46,520 | 32,483 | $1.67M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 18,935 | 12,727 | $982K |
| H2036 | Alcohol and/or other drug treatment program, per diem | 11% | 451 | 212 | $666K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.4% | 3,214 | 2,286 | $372K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 5.8% | 7,945 | 3,528 | $341K |
| 80053 | Comprehensive metabolic panel | 4.4% | 2,533 | 2,260 | $259K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 4.2% | 754 | 556 | $247K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.3% | 3,817 | 3,404 | $191K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 3,203 | 2,510 | $177K |
| 36415 | Collection of venous blood by venipuncture | 2.8% | 11,137 | 9,307 | $164K |
| A0425 | Ground mileage, per statute mile | 2.7% | 754 | 556 | $157K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 492 | 441 | $79K |
73 more codes
| 99284 | Emergency room visit (serious) | 1.1% | 318 | $63K |
| 90837 | Psychotherapy session, about an hour | <1% | 589 | $57K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 680 | $45K |
| 99307 | <1% | 984 | $30K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 678 | $26K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,044 | $22K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 619 | $22K |
| 90785 | <1% | 1,570 | $20K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 266 | $19K |
| J3490 | Unclassified drugs | <1% | 1,094 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 194 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,330 | $16K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 266 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 683 | $14K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 234 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 296 | $12K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 407 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 224 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 109 | $11K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 109 | $10K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 170 | $8K |
| 90686 | <1% | 1,041 | $7K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 206 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 172 | $6K |
| 85610 | <1% | 202 | $5K | |
| 0240U | <1% | 32 | $5K | |
| 81001 | <1% | 203 | $5K | |
| 76000 | <1% | 26 | $4K | |
| 99285 | Emergency room visit (most serious) | <1% | 22 | $4K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 35 | $4K |
| 80061 | Lipid panel | <1% | 78 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 32 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 71 | $3K |
| 0001A | <1% | 112 | $3K | |
| 99348 | <1% | 53 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 29 | $2K |
| 0002A | <1% | 86 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 42 | $2K |
| 81003 | <1% | 370 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 49 | $1K |
| 86140 | <1% | 44 | $1K | |
| 85027 | <1% | 54 | $1K | |
| 83605 | <1% | 14 | $914.60 | |
| 90461 | <1% | 181 | $867.09 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $847.61 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 197 | $782.99 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $722.75 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 24 | $701.40 |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 140 | $680.00 |
| 20610 | <1% | 20 | $517.49 | |
| 0071A | <1% | 26 | $421.13 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 28 | $380.76 |
| 99442 | <1% | 27 | $380.70 | |
| 99443 | <1% | 31 | $320.72 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 53 | $295.39 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $280.69 |
| 0012A | <1% | 13 | $252.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $239.67 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $221.15 |
| 90670 | <1% | 12 | $204.00 | |
| 90656 | <1% | 43 | $186.12 | |
| G0008 | Administration of influenza virus vaccine | <1% | 56 | $183.02 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $156.80 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13 | $130.85 |
| 90734 | <1% | 36 | $124.76 | |
| 90715 | <1% | 32 | $115.50 | |
| 87088 | <1% | 14 | $101.90 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 17 | $47.09 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 13 | $28.00 |
| 90651 | 0% | 14 | $0.00 | |
| 90685 | 0% | 25 | $0.00 | |
| 90633 | 0% | 14 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialASH, RICHARD (CEO)